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SulTlmary 
Giant cell arteritis (GCA) is a spontaneous vasculitic syndrome that specifically targets the walls 
of medium and large arteries. Vascular lesions are characterized by patchy granulomatous infiltrates 
composed of T cells, macrophages, histiocytes, and giant cells. To test the hypothesis that a locally 
residing antigen recruits T cells into the vessel walls, we have analyzed T  cell receptor (TCR) 
molecules of tissue infiltrating T  cells. A total of 638  CD4 + T  cell clones were isolated from 
temporal artery specimens of three patients with GCA. Analysis of TCR molecules for the usage 
of V/31-VB20 revealed that all TCR V/3 elements were represented, demonstrating that interleukin 
2 (IL-2)-responsive T  cells infiltrating the tissue are highly diverse.  To detect expanded T  cell 
specificities, we made use of the patchy character of the inflammatory disease and compared the 
TCR repertoire ofT cells established from independent vasculitic foci of the same artery. Sequence 
analysis of TCR V/3 chains documented that individual TCR specificities were present in multiple 
copies,  indicating clonal expansion. T  cells with identical/3 chains were isolated from distinct 
inflammatory loci of the same patient.  These specificities  represented only a small fraction of 
tissue-infiltrating T cells and involved the V/35.3 gene segment in the two patients sharing the 
HLA-DRBI*0401  allele. The third complementarity determining region of clonally expanded 
TCR/3 chains was characterized by a duster of negatively and positively charged residues, suggesting 
that the juxtaposed antigenic peptide is charged. The sharing of identical T cell specificities by 
distinct and independent regions of the granulomatous inflammation suggests that these T cells 
are disease relevant and that their repertoire is strongly restricted. These data suggest that an 
antigen residing in the arterial wall is recognized by a small fraction of CD4 + T  cells in the 
inflammatory process characteristic for GCA. 
G 
iant  cell  arteritis  (GCA) 1 is  a  vasculitis  of unknown 
etiology that occurs primarily in older individuals (1). 
Typically, inflammatory infiltrates are found in the walls of 
medium- and large-sized arteries (2). Several lines of evidence 
emphasize a role of T cells in the pathogenesis of GCA. The 
cellular infiltrate is dominated by macrophages and T  cells. 
Immunohistochemical experiments have shown that CD4 § 
T lymphocytes are the major inflammatory cell population, 
whereas CD8 + T cells are less frequent, and B lymphocytes 
are essentially absent (3). Granulocytes typically found in other 
vasculitides are apparently not involved in the arteritic lesions 
characteristic for GCA (2).  Recent genetic linkage studies 
have demonstrated an association of GCA with alleles at the 
HLA-DRB1 locus, in particular, HLA-DRBI*IM variants (4). 
Whereas the molecular basis for this genetic predisposition 
1Abbreviations used in  this paper: GCA, giant cell arteritis; HVR, 
hypervariable region. 
is unknown, it is striking that all patients with GCA share 
a sequence motif in the second hypervariable region (HVR) 
of the HLA-DRB1  gene. 
The HLA-DRB1 gene encodes for the highly polymorphic 
HLA-DR./31  chain, which on cell surfaces associates with 
a nonpolymorphic HLA-DRa  chain. The major function 
of this a-/3 complex is to present peptides to CD4 § T lym- 
phocytes (5). The shared sequence motif identified in all pa- 
tients with GCA translates into a region of the/3-pleated 
sheet of the antigen binding site of the HLA-DR molecule 
(4, 6). It has therefore been hypothesized that the inflamma- 
tory process in GCA represents a local immune response to 
an unidentified antigen (7). Further support for a local acti- 
vation of T  lymphocytes came from the recent demonstra- 
tion of locally produced IL-2 and IFN-y mRNA (8). Since 
disease-relevant antigens in GCA are not known, it is difficult 
to directly test this hypothesis. Analysis of the local T cell 
infiltrate, however, may provide information on the diversity 
of accumulated T cell specificities and may also be useful in 
identifying the relevant antigens. 
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correlation between TCR V gene usage and T  cell antigen 
recognition specificities (9-13).  For example, in experimental 
allergic  encephalomyelitis, a rat and mouse model of mul- 
tiple sclerosis, the induction of disease has been correlated 
to T cell clones specific for myelin basic protein peptides. The 
antigen specificity in this model has been strictly correlated 
with TCR V gene usage and junctional diversity (14). More 
recently, TCR sequences  with an identical sequence  motif 
in the junctional region have been obtained from demyeli- 
nated human lesions  from patients with multiple sclerosis 
(15). These studies suggest that the TCR repertoire involved 
in the pathogenesis of an autoimmune disease may be restricted 
and that the identification of disease-relevant polymorphisms 
may allow one to address the question of whether an antigen- 
driven expansion of T  cells is involved in an inflammatory 
response. 
The inflammatory response in GCA is remarkable in that 
the involvement of a given artery is characteristically focal 
and segmental (2). Here we have made use of the multifocal 
arrangement of the inflammation and have compared the diver- 
sity of the TCR repertoire of T cell clones derived from dis- 
tinct segments of the same artery. Sequence analysis of TCR 
chains demonstrated that selected T cells were present in 
multiple copies, indicating clonal proliferation in vivo. The 
repertoire of T cells involved in the inflammatory  process was 
highly restricted within one individual. Anatomically dis- 
tinct lesions were characterized by identical T cell clonotypes. 
These findings provide strong, albeit indirect, evidence for 
the model that GCA is triggered by the specific recognition 
of an antigen. 
Materials and Methods 
Patients and Tissue Samples,  Temporal  artery specimens were ob- 
tained from  three  patients  undergoing  biopsies for  diagnostic 
reasons. All specimens showed an inflammatory infiltrate by stan- 
dard histological techniques, confirming the diagnosis of GCA. 
All patients were characterized  for their HLA-DRB1 alleles  by allele- 
specific amplification  and subsequent oligonucleotide  hybridization 
as recently described (16, 17). In brief, DNA was extracted from 
PBMC and amplified with primer sets specific for the sequence 
polymorphism in the HVR1 of the HLA-DRB1 alleles. Amplified 
sequences were subsequently hybridized with oligonucleotides 
specific for polymorphisms  of  the HVR2 and HVR3. The sequences 
of the oligonucleotides and the amplification conditions have been 
described (16, 17). The HLA-DRB1 alleles of the three different 
patients were as follows: patient GCA-1, HLA-DRBl*0403/13; 
patient  GCA-2, HLA-DRB1*0401/15(16); and patient  GCA-3, 
HLA-DRB1*0401/11. 
T Cell Cloning.  The specimens  were cut into small fragments 
of "~1 mm in length. The different fragments were dispersed and 
placed into tissue culture in the presence of recombinant human 
IL-2 (20 U/ml; Cetus Corp., Emeryville,  CA). T cells had migrated 
out of the tissue within 18 h after the initiation of the cultures. 
Cultures were resuspended, and cells in suspension were directly 
cloned without additional in vitro activation in the presence of ir- 
radiated syngeneic  feeder  cells and Ib2-containing medium by lim- 
iting dilution. T cell lines and T cell clones were obtained from 
about two thirds of the tissue segments cultured, suggesting that 
about one third of the segments did not contain a T cell infiltrate. 
Established T cell clones were screened for the expression of CD4 
and CD8 markers by FACS  |  analysis (Becton Dickinson & Co., 
Mountain View, CA). The majority of T cell clones in all three 
patients expressed the CD4 marker (data not shown). The frequency 
of growth-positive wells in patient GCA-1 suggested that a signi- 
ficant number of these cultures were not clonal. Only cultures that 
were negative for CD8 § cells were further analyzed. 
V~ Gene Segment Analysis of T Cell Clones.  Total  RNA was 
extracted from CD4 + T cells by guanidium thiocyanate phenol 
chloroform extraction using a commercially available kit (RNA 
Stat; Tel Test, Friendswood, TX).  cDNA was  synthesized by 
priming with oligo dT (15 mer) and reverse transcribing with avian 
myeloblastosis  virus reverse transcriptase. VB gene segment usage 
was determined by PCK with 22 VB-specific primers and a C~- 
specific primer as recently described (18, 19). Amplified products 
were separated on 2% agarose gels and stained with ethidium bro- 
mide. We have recently shown that in the vast majority of human 
T cell clones only one rearranged V~ element can be demonstrated 
under these conditions (19). Because the limiting dilution cloning 
approach, in particular in patient GCA-1, cannot exclude biclo- 
nality, VB elements identified  in single wells were counted as inde- 
pendent clones. Sequencing  of  TCK/3 chains showed  that the V~19- 
specific primer set, which had been reported to be V~/specific  (18), 
coamplified Vj87.2. The assignment to VB7 and V~/19 (see Table 
1) has been corrected according to the sequence data. 
Sequence Analysis.  cDNA  from  selected T  cell clones was 
amplified with a C~ primer and the appropriate VB primer at- 
tached to a T7 promoter. The amplified product was transcribed 
by using a T7 KNA polymerase and then directly sequenced by 
reverse transcriptase-mediated dideoxysequencing  as recently de- 
scribed (20, 21). 
Oligonucleotide Hybridization  for CDR3 Polymorphism.  Biotin- 
conjugated oligonucleotides  specific  for CDR3 of the VB7.2 T cell 
clone C3-13 (ATCTGTATCCCTGTCCCGACG) from  patient 
GCA-1 and the Vj85.3 T cell clone MN 3-43 (GCCATAGTTAGA- 
CAGTCCCGG) from patient CGA-2 were designed, cDNA from 
PBMC and from T cell lines established from the distinct tissue 
segments was amplified with the appropriate V~specific primer 
sets. The amplified templates were adjusted. Serial dilutions were 
vacuum  blotted onto supported nitrocellulose  membranes,  prehybri- 
dized, and hybridized with the CDR3-specific probe and an in- 
ternal biotinylated  C~ probe (AGAGAGCGACCTCGGGTGGGA), 
respectively, at 55~  Blots were washed 10 rain at 42~  and 10 
rain at 55~  in 2  x  SSC 0.1 SDS, blocked with BSA blocking 
buffer, and developed  with streptavidin-alkaline  phosphatase. Signals 
were scanned using an imaging system (AMBIS, San Diego, CA). 
CDR3-specific signals were normalized to the CB-specific signal. 
Serial dilutions of cDNA from T cell clones expressing the CDR3 
sequence were used as internal standard to estimate the frequencies 
of these clonotypes in the peripheral blood and the different tissue 
specimens. 
Results 
TCR Gene  Usage of Tissue Infiltrating CD# § T  Cells.  To 
analyze the diversity of T  cell specificities recruited to the 
inflammatory lesions,  the V/3 gene  segment usage of IL- 
2-responsive T  cell clones derived from inflamed temporal 
arteries was determined. Results are summarized in Table 1. 
A total of 638 CD4 + T  cell clones were isolated from vas- 
culitic loci of three different GCA patients. All V/3 dements, 
952  T Cell Clonotypes  in Vasculitis Table  1.  TCR  Vfl Gene  Segment  Usage by  CD4 + T  Cell Clones Derived from  Vascular Infiltrates in GCA 
GCA-1  GCA-2  GCA-3 
v~ 
element  n  Percent  n  Percent  n  Percent 
1  17  4.6  11  7.0  10  8.8 
2  29  7.9  11  7.0  9  8.0 
3  8  2.2  3  1.9  0  0.0 
4  27  7.4  0  0.0  7  6.2 
5.1  24  6.5  10  6.4  10  8.8 
5.2-5.3  24  6.5  18  11.5  12  10.6 
6  47  12.8  6  3.8  18  15.9 
7  17  4.6  2  1.3  4  3.5 
8  22  6.0  10  6.4  2  1.8 
9  13  3.5  8  5.1  2  1.8 
10  25  6.9  3  1.9  0  0.0 
11  7  1.9  3  1.9  0  0.0 
12  7  1.9  7  4.5  1  0.9 
13.1  31  8.4  12  7.6  15  13.3 
13.2  11  3.0  3  1.9  0  0.0 
14  9  2.5  13  8.3  3  2.3 
15  3  0.8  0  0.0  1  0.9 
16  8  2.2  1  0.7  1  0.9 
17  9  2.5  16  10.2  6  5.3 
18  12  3.3  12  7.6  8  7.1 
19  0  0  0  0.0  1  0.9 
20  18  4.9  8  5.1  3  2.7 
except  V319,  were represented  in  CD4 §  T  cells  from pa- 
tient GCA-1. In patients GCA-2 and GCA-3, some V3 seg- 
ments were  not found at  all,  such as V1310, V~11,  V/~15, 
and VB19, which are known to be infrequently used V/3 ele- 
ments. The only remarkable finding was the nonusage of V34 
in GCA-2, and V33 and VB13.2 in GCA-3. The V3 diver- 
sity of tissue infiltrating CD4 + T  cells  resembled that found 
in peripheral blood. Vl3  gene segments frequently encoun- 
tered  in  peripheral  T  cells,  such  as  V32,  V35,  V36,  and 
V~13.1, were the dominant V3 elements in the T  cell clones 
isolated from the tissue.  Thus, IL-2R  § CD4 § T  cells in the 
vasculitic lesions are highly diverse without evidence for re- 
strictions  in  the utilization  of TCR  V/3  gene  segments. 
Clonal Expansion  of Selected  T  Cell Specificities.  The het- 
erogeneity of preactivated tissue  infiltrating  CD4 +  T  cells 
might reflect the heterogeneity of the circulating pool of preac- 
tivated T  cells or may indicate a polyclonal T  cell response 
to a variety of antigens. To identify potentially disease-relevant 
T  cells, we made use of the characteristic arrangement of vas- 
culitic loci in GCA. The inflammatory infiltrates are gener- 
ally arranged in patches with alternating areas of normal and 
inflamed tissue.  We compared the V3 usage in distinct inflam- 
matory patches from the same artery.  The results for three 
953  We)and et al. 
Figure  1.  VB gene segment usage of CD4 + T cell clones derived from 
distinct tissue segments. CD4 § T cell clones were established from three 
distinct tissue segments of an inflamed temporal artery of patient GCA-I: 
segment 1 (solid bars), segment 2 (cross-hatched  bars), and segment 3 (di- 
agonal bars). TCR V3 gene segment usage was determined by PCR with 
V~specific primers. V35.2-3, 6, 10, and 13.1 were evenly  distributed as 
were the V/3 elements not shown. VJ313.2- and V317-expressing T cells 
were enriched in segment 2, whereas V~7 and 14 were more frequently 
found only in segment 3. T
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 segments from the artery of patient GCA-1 are shown in 
Fig.  1.  Use of some V/~ families was more pronounced in 
some vasculitic loci,  but  not  others.  Uneven distribution 
among the three different biopsy segments was found for V/37, 
V(313.2, V/314, and V(317. In comparison, the V/3 distribu- 
tion for V/35.2-3,  V/36,  VB10,  and VB13.1  are shown, all 
of which were frequently used and evenly distributed between 
the different segments. 
We hypothesized that the overrepresentation of some V/3 
elements in individual inflammatory loci resulted from clonal 
expansion of selected T cell donotypes. To screen for clonally 
expanded specificities, TCR/3 chains from T cell clones ex- 
pressing  the unevenly distributed  V/~  segments were  se- 
quenced. 11 of the V/37 + T  cell clones utilized the V/37.2 
element. Among the set of 11 T cell clones, 8 expressed the 
identical TCR/3 chain, indicating that they had originated 
from a single precursor. No identical TCR sequences were 
found for the three other unevenly distributed V~ elements, 
V/313.2,  V~14, and V~17. Sequence analysis demonstrated 
that all T cell clones utilizing the evenly distributed V/3 ele- 
ments V/35.2, V~10, and V~18 expressed unique TCR/5 chain 
sequences. Thus, in this patient, clonal expansion was limited 
to V~7.2 + T  cells. 
Using the same approach, clonally expanded T cell popu- 
lations were identified in patient GCA-2 (Table 2).  In this 
patient, five expanded clonotypes were identified; three of 
them used the VB14 element and two used the V/35.3 ele- 
ment.  No clonal expansion was seen in V~2 +,  V/313.1 +, 
V/317 §  and  V/318 +  clones,  although  these VB  dements 
were frequently found and made up about one third of the 
inflammatory infiltrate. In patient GCA-3, a sufficient number 
of T cell clones was established from only one segment. Se- 
quence analysis  demonstrated clonal expansion again for a 
V/35.3  T  cell clone. 
Our data suggest that our sequencing strategy was suc- 
cessfully biased to identify expanded clonotypes in all three 
patients.  Even if we missed an expanded specificity in the 
V/3 elements that were not sequenced, the T cells which had 
undergone clonal expansion were a minority among all tissue 
infiltrating IL-2R § T cells. Clonal expansion was restricted 
to T cell clones expressing V(~7.2 in patient GCA-1, V/85.3 
and V/314 in patient GCA-2, and V/35.3 in patient GCA-3. 
Thus, patients GCA-2 and GCA-3 shared clonal prolifera- 
tion within V/35.3 + T  cells. These two patients also have 
in common the HLA-DR. allele, B1"0401,  whereas patient 
GCA-1  expressed  a  distinct  disease-linked  B1  allele,  the 
B1"0403 variant. These data suggest that the V(3 restriction 
of clonally expanded cells may be linked to the HLA-DRB1 
allele. 
Clonally Expanded T  Cell Specificities Are Residing in Dis- 
tinct Inflammatory Foci.  Using the patchy nature of the vas- 
culitic process was helpful to define a microenvironment and 
to identify clonally expanded T cell specificities. Comparing 
the composition of tissue infiltrating T  cells from distinct 
inflammatory patches could provide further evidence for the 
distinction of disease-relevant  T cells and bystander T cells. 
To approach this question, we compared the representation 
of CD4 + T cell clones isolated from independent inflamma- 
tory foci. In the two patients in whom we obtained sufficient 
numbers of T cell clones from multiple fragments, we found 
that T cells with identical TCR/3 chains were isolated from 
independent segments of the inflamed temporal arteries (Table 
3).  The clonally expanded V/37.2 + T  cell clone in GCA-1 
and  two  different V/35.3 §  T  cell clones in  GCA-2  were 
T~le  3.  D~but~n  ~  T CellCbnotyp~  wi~Iden&alTCR fl Sequenc~ 
Fragment 1  Fragment  2  Fragment  3 
V~7.2  CT1-210  -  CT3-13 
CT1-237  CT3-26 
CT2-248 
CT3-252 
CT3-253 
CT3-258 
V~14  -  MN2-205 
MN2-216 
V/35.3  MN1-59 
MN1-212 
MN1-226  MN2-246 
MN3-202 
MN3-204 
MN3-61 
MN3-220 
MN3-43 
955  Weyand  et al. localized in different patches of the inflammatory  disease. These 
findings represent a definte proof that clonal expansion oc- 
curred in vivo and was not an in vitro amplification. Use 
of identical T cells in different regions of the disease demon- 
strates that the repertoire of T cells is strongly restricted. It 
also raises the question of where these T cells are primed and 
expanded. Detection of identical T  cells in distant areas of 
the inflammatory  process makes it unlikely that they are primed 
in the arterial wall. It is more likely that selected T cell speci- 
ficities are primed outside of the artery, proliferate,  and then 
migrate into different sites of the artery where they recog- 
nize their specific antigen on the surface of an antigen-pre- 
senting cell. 
Expanded  T  Cell  Clonotypes Are Not Detectable in the Pe- 
ripheral Blood Compartment.  To address the possibility that 
the isolation of several T ceU clones with identical sequences 
resulted from a restriction within the total TCR repertoire 
of the patients, we cloned CD4 + T  cells from the periph- 
eral blood of patient GCA-2 after in vitro activation with 
immobilized anti-CD3 for 18 h and sequenced the TCR 13 
chain from V/35.2/5.3 + clones. We did not find evidence for 
clonal expansion nor did any of those T  cell clones utilize 
a TCR sequence that we had identified  in the tissue infiltrating 
T cells, suggesting that these clonal specifities were not over- 
represented in the peripheral blood  (data  not  shown).  To 
estimate the frequencies of clonotypes in the tissue and pe- 
ripheral blood compartments, we used oligonucleotide hybri- 
dization dot blot assays  for CDR3-specific sequences. Results 
for the sequence derived from a V/35.3 clonotype of patient 
GCA-2 are shown in Hg. 2. The probe was specific  for CDR3- 
specific sequences and did not crosshybridize on a T cell clone 
sharing the same V/3-J/3 combination. Two distinct tissue seg- 
ments from GCA-2 contained the CDR3 sequence, whereas 
the signal for the PBMC sample of patient GCA-2 was not 
different from the control PBMC sample.  The frequencies 
of T  cell clones expressing  the CDR3 sequence was calcu- 
lated by parallel hybridization with a C/3-specific probe (Fig. 
2).  Serial dilutions of T  cell clones  expressing  the CDR3- 
specific sequence were used as standard curve.  25 and 17%, 
respectively, of all V/35.2-3 + clones in tissue segments 1 and 
2 expressed the sequence compared with <3% of V/35.2-3 + 
PBMC from patient GCA-2 and the control individual. These 
data demonstrate that these clonotypes are locally accumu- 
lated and/or expanded and are not overrepresented  in the 
PBMC. 
Characteristics of Clonally Expanded  CD4 + T  Cells.  The 
clonal expansion of selected T cells and their presence at dis- 
tinct sites of the inflamed artery suggests that these T  cells 
are potentially disease relevant, whereas the accumulation of 
nonexpanded T cells may only reflect their homing pattern. 
Comparison of the TCR molecules of these two T cell popu- 
lations may provide information on the nature of the antigens 
Figure  2.  Representation  of CDR3-specific sequences  in PBL and temporal artery  specimens. T cell lines were established  from  two segments, seg- 
ment 1 and 2, of the temporal artery specimen  of patient GCA-2 (lines  3-4), cDNA was amplified  with a V/35.2-3-specific  primer set and compared 
with the amplified  products derived from PBL from patient GCA-2 (line 5) and a control individual  (line 6). T cell clones MN 1-59 and MN 1-212 
(lines I-2), which  have  identical  TCR sequences  and were established  from  segment  1, served  as positive  control. T cell  clone  MN 2-205, which  expressed 
an unrelated CDR3 sequence, was used as negative  control (line 7). Results are shown for serial dilutions  of the amplicons after  hybridization  with 
a CDR3-specific  probe (A) and a CB-specific  probe (B). CDR3-specific  sequences  were  found  in both tissue  specimens,  but not in a significant  concentra- 
tion in the PBL population from the same patient. 
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Patient  T  cell clone  V/3  N-D-N region  J~ 
GCA-1  CT3-13  7.2  R R ~  T  D  Q Y T  F (1.2) 
GCA-3  DU1-18  5.3  P ~  G  S T  D T  Q Y  F (2.3) 
GCA-2  MN3-202  14  N D P R R  P  L  H F(1.6) 
GCA-2  MN2-205  14  V Q G F IQ  G  T1  E A  F  F(1.1) 
GCA-2  MN3-61  14  L  E [~  E  T  Q  Y  F (2.5) 
GCA-2  MN2-246  5.3  F [Q  G  SIN  Q P Q H F (1.5) 
GCA-2  MN3-43  5.3  P  G  L  S  N  Y  G  T  F(1.2) 
that are specifically recognized. To address this question, we 
analyzed the usage of amino acid residues in the CDR3 re- 
gion of clonally expanded and nonexpanded T cells isolated 
from the inflamed tissue. 
The N-D-N region of three of the seven expanded T  cell 
clones contained a high number of charged residues  (Table 
4).  This  was  particularly evident  for  the  V37.2 +  T  cell 
clonotype which used a repetitive sequence of Arg and Glu. 
The total net charge for the three T cell clones with charged 
residues  in the CDR3 was different. However, two clones 
had a DRD  or DRE motif in the central position of the 
CDR3,  suggesting  that  the  interacting  protein  includes 
charged amino acids. A  second motif was identified in ex- 
panded TCR molecules of patient GCA-2. Three of the five 
TCR  used  the  QGS/T  motif.  While the DRE  motif is 
charged,  amino acids in  the QGS  motif may function as 
hydrogen donors in the interaction with a charged peptide. 
The distribution of amino acids in the CDR3 of nonex- 
panded T cell clones was very similar to amino acid use de- 
scribed by Prochnicka-Chalufour et al. (22) (Table 5).  Gly, 
Thr, and Ser were frequently used. Negatively and positively 
charged residues  accounted for slightly more than 20%  of 
all amino acids. The donally expanded T cells were charac- 
terized by a preferential usage of charged amino acids. In par- 
ticular,  Asp, Arg, and Gln were frequently encountered and 
may be involved in hydrogen bonds. This structure of the 
Table  5.  Usage of Amino Acid Residues in the CDR3  of CD4 + T  Cells Isolated from Inflammatory  Infiltrates 
Amino acids (Percent TCR3-CDR3) 
Clonally Expanded  Nonexpanded  Prochnicka-Chalufour 
Amino Acid  T  cells  T cells  et al. (22) 
Aspartic Acid  13.6  4.0  10.6 
Arginine  13.6  9.5  5.7 
Glycine  13.6  16.0  17.7 
Glut amine  11.4  4.7  5.3 
Threonine  9.0  10.2  8.5 
Glutamic Acid  6.8  7.3  3.9 
Serine  6.8  8.4  11.3 
Proline  6.8  6.2  1.4 
Asparagine  6.8  6.5  8.1 
Leucine  4.5  5.0  6.7 
Phenylalanine  4.5  0.7  1.0 
Valine  2.3  3.3  2.1 
Alanine  0.0  5.8  7.1 
Tyrosine  0.0  3.3  4.6 
Lysine  0.0  4.4  0.3 
Isoleucine  0.0  1.5  2.1 
Tryptophan  0.0  3.3  2.5 
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negatively and positively charged residues. 
Discussion 
To evaluate the contribution  of CD4 + T  cells to the in- 
flammatory infiltrate in GCA, we have analyzed the diver- 
sity of tissue infiltrating  CD4 § T  cells.  Data  described in 
this report demonstrate that a highly heterogeneous popula- 
tion of CD4 + T cells is recruited to the vasculitic infiltrates. 
A small percentage of T  cells have undergone clonal expan- 
sion, suggesting an antigen-specific response. The composi- 
tion of the T  cell infiltrate  in this vasculitic response pro- 
poses the model that  a small fraction of disease-relevant  T 
cells are surrounded by T cells attracted to the inflammatory 
site by antigen-nonspecific mechanisms.  Most importantly, 
identical clonotypes had infiltrated the tissue at independent 
sites, indicating that  the TCR repertoire for a putative dis- 
ease relevant  antigen  in GCA patients  is limited. 
GCA represents a unique model of an inflammatory dis- 
ease in humans.  In general,  the patients have sudden onset 
of disease, and by the time temporal artery tissue is obtained 
for diagnostic reasons,  the disease  is in  an  early and acute 
stage (1). For other chronic inflammatory diseases, it has been 
argued that  the composition of the inflammatory infiltrate 
changes over time with an initial dominance of an antigen- 
specific  response but  recruitment  of highly  diverse T  cell 
specificities  during chronic disease (23, 24). All patients ana- 
lyzed in this report underwent biopsy within 2 wk after onset 
of symptoms.  Thus,  the CD4 + T  cell population  isolated 
from the inflamed arteries should be representative  of the acute 
disease  process. 
To focus on relevant T  cells, we selected for IL-2-respon- 
sive CD4 §  T  cells.  It  is  a reasonable  assumption  that  all 
CD4 + T  cells proliferating  to low doses of IL-2 have been 
recently activated. The wide spectrum of IL-2R-expressing 
T  cells  accumulated  in  the vasculitic lesions indicates  that 
recruitment  mechanisms  are not selective.  Similar observa- 
tions have been described for antigen-specific responses to ex- 
ogenous antigens.  Doherty et al.  (25) have determined  the 
frequencies of influenza virus-specific T cells in different target 
tissues of virus-infected mice and have described that '~50% 
of locally infiltrating cells secrete lymphokines, whereas only 
1%  are antigen  specific.  Recently activated T  cells,  as well 
as memory cells, are apparently equipped to migrate into tissue 
in search of their relevant antigen (26, 27). Areas of inflam- 
mation  thus enrich  for such T  cells  and include a random 
representation  of currently activated CD46 + T  cells in the 
circulation. 
To define a T  cell population  that is potentially relevant 
to the disease process, we have chosen to define local clonal 
expansion of a T  cell clonotype as a criterion.  The fact that 
T  cells  with  identical  TCR  ~  chains  were isolated  from 
different and nonadjacent segments of tissue emphasizes the 
interpretation  that  replicate copies of the expanded T  cells 
did indeed develop in vivo and were not simply an artifact 
of in vitro T  cell isolation.  There are several possible expla- 
nations for encountering replicate copies of the same T cells 
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in different tissue segments.  In the first model,  T  cells are 
primed outside of the artery and are independently recruited 
to the inflammatory foci. Alternatively, T cells first replicate 
within the inflammatory vasculitic infiltrate.  In this model, 
T cells would have to leave the arterial wall after antigen contact 
in the inflammatory lesions and recirculate.  Our data on the 
representation of these clonotypes in tissue and in peripheral 
blood (Fig.  2) do not exclude that these cells are present in 
the blood compartment, however, the frequency must be very 
low compared with  the  frequencies in the  tissue.  In both 
models,  the repertoire  of disease-relevant  T  cells  triggered 
by an autoantigen  or exogenous antigen would have to be 
highly restricted  and involve only a few clonotypes. 
Clonal expansion was limited to T  cells utilizing V~/7.2 
in the HLA-DRBI*0403 § patient and V/35.3  and V/314 in 
the HLA-DRBI*0401 § patients.  This restriction  supports 
the hypothesis that the clonally expanded T cell are specific 
for an antigen.  There was no evidence for an overall  over- 
representation of those V~ families,  and the composition of 
the inflammatory T cell infiltrate does not suggest the action 
of a superantigen. Several animal models of autoimmune dis- 
eases have suggested that the autoimmune response is trig- 
gered by a limited number of T  cell specificities  that recog- 
nize an autoantigenic  peptide in restriction  to MHC class 
II molecules.  In general,  these autoimmune diseases have been 
induced by immunization with autoantigens or by antigens 
closely related to autoantigens in the presence of adjuvants 
(14, 28, 29). It remains to be proven whether the pathomecha- 
nism implied in these animal models are functional in chronic 
inflammatory diseases which spontaneously arise in suscep- 
tible patients.  Recent studies by Oksenberg et al. (15) sug- 
gest that this indeed might be the case. These authors have 
observed  identical  clonotypes  in  different  plaques  and  in 
different patients with multiple sclerosis. In these studies, T 
cells were not  isolated.  Therefore,  the question cannot  be 
directly  addressed  whether  the  TCR  share  an  antigen 
specificity. However, homology data of the CDR3 suggested 
that these TCR may be directed to the myelin basic protein. 
In contrast to multiple sclerosis, GCA has the advantage that 
tissue is readily available at very early stages of the disease. 
Our data support the model that  the repertoire of disease- 
relevant T cells during the early stages of the disease is highly 
restricted, suggestive of an antigen-specific response. The na- 
ture of this antigen in GCA is unresolved. The arrangement 
of the granulomatous lesion in the media of the artery and 
the destruction of the elastic lamina has raised the hypothesis 
that  elastic fibers  represent  a target  antigen  of the disease. 
The clinical  presentation  of patients with GCA is not easy 
to reconcile with this model. Patients present with an acute 
onset of the disease,  suggesting an exogenous antigen.  The 
disease usually has a self-limiting course and goes into spon- 
taneous remission after 1-2 yr, suggesting that the immune 
response in GCA patients is not directed to a widely present 
autoantigen such as elastin. In support of this view, we have 
shown  that  the  disease-implicated  T  cell  clones  do  not 
proliferate in response to elastin  (data not  shown). 
Analysis of the amino acid use in the CDR3 of the puta- 
tively relevant T  cell clones may allow one to speculate on the nature of the stimulating antigen. Several features were 
unique for the T cell clones isolated from the temporal ar- 
tery. Three out of the seven T cell clones used a repetitive 
stretch of positively and negatively charged amino acids. Most 
striking was the finding of the RRDRDTD  motif in the 
VBT.2 + T  cell clones.  This clustering of charged residues 
suggests that the corresponding antigenic peptide may be 
charged as well. The second set of T cell clones was charac- 
terized by the motif QGS/T. Whereas it cannot be predicted 
that these T cell clones recognize the same antigen, it is pos- 
sible that these amino acids are involved in hydrogen bonds 
with a charged antigenic peptide.  These observations may 
be helpful to define candidate antigens in narrowing down 
the spectrum of antigens potentially recognized by these TCR 
specificities. Ultimately, the nature of the antigen has to be 
demonstrated in direct biological assays. The donaUy expanded 
T cells isolated from the inflammatory  lesions represent unique 
reagents to search for the relevant  antigen. 
Current therapies  of GCA are focused on the use of corti- 
costeroid which cannot shorten the disease process  and, in 
many patients, is accompanied by serious  side effects. Sup- 
pressing the inflammatory response in GCA patients with 
more specific means would improve our management of these 
patients. One of the conclusions of this study is that the frac- 
tion of disease-relevant T  cells is probably very small.  This 
might explain why experimental approaches using V/3 reper- 
toire studies in human autoimmune disease have been of very 
limited success (24,  30-33).  However, the ability to define 
disease relevance for a small subset of T cells that cannot be 
detected by crude approaches, such as V/3 analysis, would open 
the possibility to spare the majority ofT cells and target the 
minor subset that appears to initiate and maintain the chronic 
destructive inflammation. 
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